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Embryonic eyelid closure involves forward movement and ultimate fusion of the upper and lower
eyelids, an essential step of mammalian ocular surface development. Although its underlying
mechanism of action is not fully understood, a functional mitogen-activated protein kinase kinase
kinase 1 (MAP3K1) is required for eyelid closure. Here we investigate the molecular signatures of
MAP3K1 in eyelid morphogenesis. At mouse gestational day E15.5, the developmental stage immedi-
ately prior to eyelid closure, MAP3K1 expression is predominant in the eyelid leading edge (LE) and the
inner eyelid (IE) epithelium. We used laser capture microdissection (LCM) to obtain highly enriched LE
and IE cells from wild type and MAP3K1-deﬁcient fetuses and analyzed genome-wide expression
proﬁles. The gene expression data led to the identiﬁcation of three distinct developmental features of
MAP3K1. First, MAP3K1 modulated Wnt and Sonic hedgehog signals, actin reorganization, and
proliferation only in LE but not in IE epithelium, illustrating the temporal-spatial speciﬁcity of MAP3K1
in embryogenesis. Second, MAP3K1 potentiated AP-2a expression and SRF and AP-1 activity, but its
target genes were enriched for binding motifs of AP-2a and SRF, and not AP-1, suggesting the existence
of novel MAP3K1-AP-2a/SRF modules in gene regulation. Third, MAP3K1 displayed variable effects on
expression of lineage speciﬁc genes in the LE and IE epithelium, revealing potential roles of MAP3K1 in
differentiation and lineage speciﬁcation. Using LCM and expression array, our studies have uncovered
novel molecular signatures of MAP3K1 in embryonic eyelid closure.
& 2012 Elsevier Inc. All rights reserved.Introduction
MAP3K1, also known as MEK kinase 1 (MEKK1), is a serine/
threonine protein kinase of the MAP3K superfamily (Davis, 1995).
This family consists of at least 21 members, responsible for
activation of the MAP2K–MAPK cascades and regulation of a wide
variety of biological functions (Craig et al., 2008). In vitro studies
show that MAP3K1 speciﬁcally activates the MAP2K4 and MAP2K7
kinases, which in turn phosphorylate the c-Jun N-terminal kinases
(JNKs) and/or p38 MAPKs, whereas in vivo studies have shown that
MAP3K1 has diverse roles in the biological systems (Xia et al.,
1998; Yan et al., 1994; Yujiri et al., 1998). The in vivo data
collectively show that MAP3K1 regulates T and B cell-mediated
immune responses, erythropoiesis and cardiogenesis; in addition,
MAP3K1 plays a pivotal role in ocular surface morphogenesis
during embryonic development (Gallagher et al., 2007;Gao et al.,ll rights reserved.2004;Geh et al., 2011;Labuda et al., 2006; Minamino et al., 2002;
Venuprasad et al., 2006).
Mammalian ocular surface development involves the transient
closure and re-opening of the eyelid (Findlater et al., 1993).
In mice, eyelid development begins at embryonic day 12–13
(E12–13), when the surface ectoderm adjacent to the developing
cornea folds to form the lid buds. The eyelid at this stage is a
simple structure consisting of surface periderm covering undif-
ferentiated mesenchyme. From E13 onward, the eyelid grows
toward the center of the ocular surface. Between E15.5 and E16, a
massive morphological change occurs at the junction of the outer
and inner eyelid epithelium, causing the eyelid tip cells to
elongate and migrate, leading to ultimate fusion of the upper
and lower eyelids. Mouse eyelid remains closed between E16.5
and postnatal day 12–14, during which time the outer layer
epithelium differentiates towards epidermis, the inner layer
becomes conjunctiva, and the underlying mesenchyme derived
from the migrating neural crest cells begins to form muscle,
tarsus and other connective tissues. Eyelid re-opening takes place
two weeks after birth, when cells at the fusion junction undergo
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with normal embryonic eyelid closure have their eyelids closed at
birth, mice with defective embryonic eyelid closure exhibit an eye
open-at-birth (EOB) phenotype.
In mice, deletion of either the full-length (MAP3K1-null or
Map3k1 /) or the kinase domain (Map3k1DKD/DKD) of MAP3K1
results in the EOB phenotype (Yujiri et al., 2000; Zhang et al., 2003).
Immunohistochemical analyses show that theMap3k1DKD/DKD fetuses
have decreased phosphorylation of MAP2K4 and JNK in the eyelid tip
epithelial cells (Takatori et al., 2008), whereas genetic studies show
that although one functional Map3k1 allele is sufﬁcient for normal
eyelid closure, it becomes haploinsufﬁcient for eyelid closure in
Jnk1/ and Jnk1þ /Jnk2þ / mice. These observations suggest that
MAP3K1 regulates at least partly embryonic eyelid closure through
activation of the MAP2K4–JNK pathways.
c-Jun, a member of the AP-1 group of transcription factors, is a
potential downstream effector of this pathway. Phosphorylation
of c-Jun by JNK at the N-terminal serine 63 and 73 is an important
mechanism of AP-1 activation, because N-terminal phosphoryla-
tion promotes c-Jun dissociation from a transcriptional repressor
complex, resulting in transcriptional activation of target genes
(Aguilera et al., 2011). We showed that c-Jun N-terminal phos-
phorylation and AP-1 activity was much lower in the eyelid tip
epithelial cells of Map3k1DKD/DKD compared to wild type fetuses
(Geh et al., 2011; Takatori et al., 2008). However, lacking c-Jun
phosphorylation cannot be responsible solely for defective eyelid
closure. Transgenic mice harboring a mutant c-Jun with serines
63 and 73 replaced by alanines {c-Jun (AA)} completely lack c-Jun
N-terminal phosphorylation, but have normal eyelid development
(Behrens et al., 1999), suggesting that phosphorylation of c-Jun is
dispensable for embryonic eyelid closure. Hence, the MAP3K1–
JNK axis must regulate eyelid closure through other downstream
effectors whose identities are still unknown.
In the present work, we have used global gene expression analyses
to identify regulatory processes downstream of MAP3K1 critical in
eyelid development. We found that MAP3K1 was abundantly
expressed in the eyelid leading edge (LE) and inner eyelid (IE)
epithelium of the developing fetuses. We used Laser Capture Micro-
dissection (LCM) to isolate these cells from wild type andMap3k1DKD/
DKD fetuses at embryonic day 15.5, a developmental stage immedi-
ately prior to eyelid closure. Gene expression signatures in LE and IE
cells provide novel insights into the role that MAP3K1 plays in eyelid
morphogenesis.Materials and methods
Experimental animals, cells and reagents
Map3k1þ /DKD mice were previously described (Xia et al., 2000;
Zhang et al., 2003) and were backcrossed to the C57BL/6 back-
ground for seven generations. The fetuses were collected at E15.5
and genotypes were determined by PCR. Experiments conducted
with these animals have been approved by the University
of Cincinnati Animal Care and Use Committee. Antibody for
b-catenin was from Sigma, phospho-H3 was from Millipore,
a2-actin and SK myosin were from Thermal Scientiﬁc and Abcam,
respectively. The HEK293 cells were purchased from American
Type Culture Collection (ATCC). The Wnt3a expression vector,
TCF/LEF DNA-binding sites-driven luciferase reporter (TCF/LEF-
luc) and SRE-luc plasmids were kindly provided by Drs. Xinhua
Lin (Cincinnati Children’s Hospital Medical Center), Yujin Zhang
(University of Cincinnati), and Jinsong Zhang (University of
Cincinnati), respectively (Belenkaya et al., 2008; Hu et al., 2011).
The AP-1-luc, SBE-luc and the MAP3K1 mammalian expression
vector were described before (Zhang et al., 2005). The wild type{MAP3K1(WT)} and kinase-inactive {MAP3K1(KM)} mammalian
expression plasmids were described before (Xia et al., 1998).
Tissue and cell preparation, RNA and cDNA generation and
microarray
For LCM, the heads of E15.5 fetuses were embedded in Tissue-
Tek OCT medium (Sakura Finetek USA) and stored in 80 1C.
Eight mm coronal sections were mounted on plain uncoated glass
slides, dehydrated and stained with HistoGene LCM frozen section
staining kit, and were used for LCM following the manufacturer’s
protocol (Molecular Devices). Cells from 4 sections were collected
on one LCM cap within one hour of collection to avoid RNA
degradation. The cells were lysed in 100 ml Trizol (Invitrogen,
Carlsbad, CA) at room temperature for 5 min and stored at
80 1C. It was estimated that 50 sections (12 caps) were
processed for each fetus, which together generated 2000 cells
from the LE and 3000 cells from the IE eyelid epithelium. The
lysates from each fetus were pooled and processed as one
biological sample.
The lysates were mixed with 0.1% Linear Acrylamide (Ambion,
Austin, TX) and RNA was extracted by two rounds of chloroform
phase separation and isopropanol precipitation, followed by
washing three times with 75% ethanol. Samples were air dried
and dissolved in 10 ml nuclease-free water. It was estimated that
10 ng and 15 ng total RNA were obtained from LE and IE eyelid
epithelium, respectively, per fetus. RNA was analyzed by Agilent
2100 Bioanalyzer (Agilent, Santa Clara, CA) and samples with RNA
Integrity Number (RIN) 45.5 were processed for cDNA ampliﬁca-
tion. cDNA ampliﬁcation and biotinylation was done using
Ovation Pico WTA System (NuGEN, San Carlos, CA) following
the manufacturer’s instructions. Speciﬁcally, RNA (10 ng) was
processed into ﬁrst strand cDNA, a DNA/RNA heteroduplex, and
thereafter a linear isothermal ampliﬁed cDNA. The ampliﬁed
cDNA was puriﬁed with a PCR Puriﬁcation Kit (QIAGEN,
Valencia, CA).
The cDNAs from each fetus were considered one biological
sample and 3 samples of each genotype were used for triplicate
hybridization on the Affymetrix GeneChip Mouse Gene 1.0 ST
array (P/N 901168, Affymetrix, Santa Clara, CA). The arrays are
hybridized with 15 mg of fragmented aRNA. The hybridization,
staining, and washing are carried out using the Affymetrix
GeneChip Hybridization Wash and Stain Kit (P/N 900720) follow-
ing the manufacturer’s protocols. The arrays are hybridized for
16 h at 45 1C using Affymetrix Hybridization Oven 640 (P/N
800139). FS450_0001 protocol is used for staining and washing
the GeneChips using the Affymetrix Fluidics Station 450 (P/N 00-
0079). The GeneChips are scanned with Affymetrix GeneChip
Scanner 3000 7G Plus using Affymetrix GeneChip Command
Console 3.2.3.1515 software and Affymetrix preset settings.
Quantitative RT-PCR
Quantitative PCR was performed using an MX3000p thermal
cycler system and SYBR Green QPCR Master Mix (Stratagene),
using conditions optimized for each target gene primers with
efﬁciency greater than 85%, cycles less than 28 and sample
locations on the plates been randomized. The PCR products were
subjected to melting curve analysis and the relative cycle differ-
ences in qRT-PCR were determined using DCt, as described
(Schnekenburger et al., 2007). The DCt value for each sample
was determined using the cycle threshold (Ct) value of the
speciﬁc gene normalized to that of Gapdh. The fold change was
calculated based on the ratio between treated versus untreated
(control) samples, designated as 1. Data are based on triplicate
reactions of at least three biological samples.
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Whole mount X-gal staining, immunostaining and H&E stain-
ing were done using standard protocols as previously described
(Mongan et al., 2008).
Transfection and luciferase assay
Cells seeded in 24-well tissue culture plates at 1105 cells/
well were grown for 16 h before transfection. Transfection was
carried out with Lipofectamine Plus reagent (Invitrogen), using
speciﬁc-ﬁreﬂy luciferase and CMV-renilla luciferase plasmids
following the manufacturer’s instructions. In some experiments,
cells were co-transfected with Wnt3a and/or MAP3K1 expression
vectors as described elsewhere (Belenkaya et al., 2008; Zhang
et al., 2005), and in some others, the cells were treated with LiCl
(20 mM) for 24 h. Twenty-four to thirty-six hours after transfec-
tion, cells were lysed and luciferase activities were determined
using dual luciferase reporter kits (Promega).
Statistical and bioinformatics analyses
Microarray data were analyzed at gene level using statistical
software R and the limma package of Bioconductor (Smyth, 2004)
with custom CDF downloaded from BrainArray (Dai et al., 2005).
Data pre-processing, including background correction and normal-
ization, was performed using RMA. Array quality was assessed using
the Array Quality Metrics package of Bioconductor (Kauffmann et al.,
2009). Fold change was calculated by a separate linear model for
each gene using limma package, and resulting t-statistics were
modiﬁed using an intensity-based empirical Bayes method (IBMT)
(Sartor et al., 2009b). Fold change of a gene is calculated as the ratio
of average intensity of the gene in one genotype to the other. By
convention, when the fold change is less than 1, the negative of its
inverse is used.
Using IBMT p-values as the measure of statistical signiﬁcance,
functional enrichment analysis was performed using the logisticR
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Fig. 1. MAP3K1 expression and function in developing eyelids. (A) Photographs show
Arrows point at developing eyelids, showing that the eyelids are fully open in E15.5 fet
fetuses. (B) X-gal stained Map3k1 heterozygous fetuses (Map3k1þ /DKD) at E15.5 were se
after (lower left) LCM, and the captured leading edge eyelid (LE) (upper right) and inner
subjected to qRT-PCR using primers for the kinase domain of Map3k1 (Map3k1) and b-g
sample, and compared to the expression in wild type cells, set as 1. The results are show
sample. Statistic analyses were done by Student t-test, nnpo0.01 is considered signiﬁcregression based LRpath methodology (Sartor et al., 2009a) as
implemented in the R package CLEAN (Freudenberg et al., 2009).
The gene list used in the functional enrichment analysis came
from genes associated with Gene Ontology terms (Ashburner
et al., 2000), KEGG pathways (Kanehisa et al., 2008), MSigDb
database (Subramanian et al., 2005) and mammalian phenotypes
(Blake et al., 2009). The statistical signiﬁcance of gene list
enrichment was determined based on the False Discovery Rate
(fdr) cut-off of 0.1. Genes that were both members of at least one
statistically signiﬁcant gene list and had IBMT p-value o0.05
were considered to be differentially expressed.
The transcription factors (TF) whose target genes were enriched
for differentially expressed genes were identiﬁed based on LRpath
analysis of computationally derived lists of targets in MSigDb data-
base (Subramanian et al., 2005) and in-house derived lists previously
described in (Medvedovic et al., 2009) using the same fdr signiﬁcance
levels as for functional enrichment analysis.
Real-time RT-PCR and quantitative imaging data were sub-
jected to statistical comparisons with Student’s two-tailed paired
t-test and analysis of variance (ANOVA). Data represent the
average7s.d. from at least three independent experiments.
Values of npo0.05, nnpo0.01 and nnnpo0.001 were considered
statistically signiﬁcant.Results
Eyelid leading edge (LE) and inner eyelid (IE) epithelia show distinct
MAP3K1-regulated gene expression signatures
Mouse embryonic eyelid closure is a precisely orchestrated mor-
phogenetic event, taking place within a narrow window of fetal
development. The upper and lower eyelids are separated at E15.5, but
they are fully closed and fused at E16.5 (Fig. 1A). In contrast to the
wild type and heterozygous (Map3k1þ /DKD) fetuses, in which the
eyelids were closed at E16.5, the knockout (Map3k1DKD/DKD) fetuses
had their eyelids widely open. To identify the cells directly affected byLeading edge eyelid 
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Fig. 2. The Map3k1 mRNA levels in wild type and Map3k1DKD/DKD cells.
(A) A schematic illustration of Map3k1 genome map. The hybridization signal
intensity of Map3k1 exon probes with RNA isolated from wild type and
Map3k1DKD/DKD (B) IE, and (C) LE epithelium. Data represent the average intensity
of the probes for each exon. Statistic analyses are done by student t-test comparing
the intensity in wild type and Map3k1DKD/DKD. npo0.05 and nnpo0.01 are
considered signiﬁcant. LE, leading edge eyelid, IE, inner eyelid.
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ing eyes by taking advantage of theMap3k1DKD allele, which contains
the bacterial b-galactosidase gene knocked-in into the Map3k1
locus (Xia et al., 2000). After whole mount X-gal staining of the
Map3k1þ /DKD fetuses, we measured b-gal expression as a surrogate
for the expression of the endogenous MAP3K1 protein. The b-gal
positive cells were most abundant in eyelid epithelium, and were
almost undetectable in eyelid dermis and cornea (Fig. 1B). In addition,
the b-gal positive cells were particularly enriched in the LE and IE
epithelia, but were sparse in the epithelium of outer eyelid and skin.
This pattern of expression prompted us to focus on the analysis of
MAP3K1’s functions in LE and IE epithelia.
Developmentally, the eyelid epithelium originates on E11–12
from the surface ectoderm, which folds to divide the outer and
inner eyelid epithelium. After the initial division, the outer eyelid
epithelium continues to differentiate towards epidermal lineages,
and the IE epithelium is programmed to become conjunctiva
(Wolosin et al., 2004). The LE, located at the crossroad junction of
outer and IE epithelium, consists of a group of periderm cells that
change their shape during eyelid closure. Because of their distinct
characteristics and developmental fates, the LE and IE cells might
be affected differently by MAP3K1 ablation. To identify the
effects, we isolated LE and IE cells separately by LCM from
E15.5 wild type and Map3k1DKD/DKD fetuses, the eyelids of which
were morphologically indistinguishable at the optical microscopic
level at this time point (Fig. 1B). We ﬁrst examined MAP3K1
expression by real-time RT-PCR, using primers recognizing either
Map3k1 exon 18, speciﬁcally deleted, or b-gal, uniquely present,
on the Map3k1DKD allele. The level of b-gal mRNA was signiﬁ-
cantly lower in wild type than in Map3k1DKD/DKD embryos,
whereas the level of Map3k1 exon 18 was about 100-fold more
abundant in wild type than in knockout cells (Fig. 1C). These
results conﬁrm the wild type and mutant Map3k1 status at the
mRNA level in the captured LE and IE epithelial cells.
We next examined global gene expression in these cells. We
detected abundant mRNA for at least 15 cytokeratins and/or
keratin-associated proteins, the majority of which were expressed
equally in wild type and Map3k1DKD/DKD cells with only a few
exceptions (Supplemental Table I). These observations suggest that
the LCM captured wild type and Map3k1DKD/DKD samples have
equivalent numbers of epithelial cells. Statistical analyses of the
array data led to the identiﬁcation of a total of 797 differentially
expressed genes in LE and 1189 differentially expressed genes in IE
epithelial cells (GEO repository, accession no. GSE39240). Unex-
pectedly, however, Map3k1 was not one of the differentially
expressed genes. We argued that because the Map3k1DKD allele
had only exons 15–21 deleted, the differential expression of these
exons was masked when the full length mRNA was analyzed (Xia
et al., 2000). To test this hypothesis, we examined the array signals
generated by 84 oligo probes covering all 21 exons of the Map3k1
gene. The probes for exons 1–14 produced signals with equal
intensity in wild type and knockout cells, whereas probes for exons
15–17 detected signiﬁcantly weaker signals in Map3k1DKD/DKD LE
and IE cells and probes for exons 18–21 had poor hybridization
quality (Fig. 2). Hence, the regions missing on theMap3k1DKD allele
had decreased expression in the knockout cells.
Bioinformatics analyses of the array data generate a list of
statistically signiﬁcant functional categories (supplemental Tables
II–IX). The statistically signiﬁcant functional categories associated
with 12 dominant functional themes are listed in Table 1.
Differentially expressed genes associated with these functional
categories are listed in Tables 2–5, and Supplemental Tables
X–XXVII. Strikingly, more than 95% of the differentially expressed
genes in the LE are distinct from those in the IE epithelial cells,
underscoring an exceptional temporal-spatial speciﬁcity of
MAP3K1 in the developing eyelid.MAP3K1 potentiates morphogenesis of the LE eyelid epithelium
Histological examination indicates that the LE cells of wild type
fetuses undergo major morphological changes during embryonic
eyelid closure, whereas those of Map3k1DKD/DKD fetuses do not
(Zhang et al., 2003). Gene expression data provided a molecular basis
to this observation, as they showed that the Map3k1DKD/DKD LE cells
had decreased expression of genes involved in morphogenesis, actin
re-organization, and migration (Table 1). For example, compared to
wild type cells,Map3k1DKD/DKD LE cells had less expression of Ephrin-
A1 (Efna1), a crucial migration and morphogenetic factor, Palladin
(Palld), responsible for organization of actin cytoskeleton, and Keratin
17 (Krt17) and a2-actin, markers for cell migration and epithelium-
to-mesenchymal transformation (EMT) (Table 2 and Fig. 3A).
MAP3K1 has been shown to regulate B cell proliferation by
mediating CD40 ligand-induced cyclin D2 expression (Gallagher
et al., 2007), but its role in eyelid cell proliferation has not been
reported. Our gene expression data identiﬁed a number of pro-
proliferative genes expressed less abundantly in the knockout LE
cells (Supplemental Table X). For example, relative to wild type cells,
Map3k1DKD/DKD LE cells had reduced expression of ﬁbroblast growth
factor 7 (Fgf7), a major mitogenic and survival factor invo-
lved in proliferation and morphogenesis, and teratocarcinoma-
derived growth factor 1 (Tdgf1), an epidermal growth factor-related
protein with an essential role in cell proliferation (Table 2 and
Fig. 3A). To evaluate whether cell proliferation was affected by
MAP3K1, we examined the phosphorylation of histone H3, an event
required for chromatin ﬁber decondensation, and chromosome
compaction during mitosis. Phospho-H3 positive nuclei were
observed in the epithelium and dermis of the E15.5 developing
eyelids (Fig. 3B). While phospho-H3 positive nuclei were detected
Table 1
Classiﬁcation MAP3K1-regulated genes in LE and IE eyelid epithelium.
MAP3K1-dependent genes in LE
Morphogenesis GO:0048598, GO:0035239, GO:0010926, GO:0016331, GO:0048729, GO:0009888, GO:0048730, GO:0031069, GO:0060512,
GO:0048858, GO:0007440, GO:0042733, GO:0060425, GO:0000902, GO:0010770, GO:0009790, GO:0001763, GO:0035239
GO:0060571, GO:0061138, GO:0042472, GO:0060572, GO:0042471, GO:0048646, GO:0045684, GO:0008544, GO:0045682,
GO:0022612, GO:0002009, GO:0060443, GO:0048557, GO:0048596, GO:0048048, GO:0032989, GO:0003007, GO:0060740,
GO:0009887,GO:0007435, GO:0060325, GO:0060562, GO:0060688, GO:0090103, GO:0010171, GO:0060323, GO:0048754,
Proliferation GO:0048146, GO:0002053, GO:0042127, GO:0010463, GO:0050679, GO:0010464, GO:0050678, GO:0048144,
GO:2000179, GO:0008285, GO:0050673, GO:0021936, GO:0043616, GO:2000177, GO:0048145,
Actin cytoskeleton GO:0007010,GO:0030036 , GO:0008092, GO:0005925, GO:0003779, GO:0015629, GO:0030029, GO:0032432, GO:0032970,
GO:0030832, GO:0051017, GO:0030048, GO:0031532, GO:0001725, GO:0007010, GO:0007015, GO:0032956,
GO:0008154, GO:0030042, GO:0030834, GO:0008064, GO:0051015,
Hair follicle GO:0001942, GO:0031069, GO:0022405, GO:0042633, GO:0042303
Hedgehog pathway GO:0007224, GO:0008589, GO:0045880
Wnt pathway mmu04310, GO:0016055, GO:0060070, GO:0030178, GO:0060828, GO:0030111, GO:0090090, GO:0090263
Notch pathway mmu04330
MAP3K1-repressed genes in LE
Lens GO:0005212, GO:0002088
Keratinocyte differentiation GO:0001533, GO:0030216, GO:0030216, c2:1718
MAP3K1-dependent genes in IE
Morphogenesis GO:0009887, GO:0048730, GO:0060425, GO:0060441, GO:0035239, GO:0003382, GO:0009887, GO:0048562, GO:0002009,
c5:377, GO:0072088, GO:0048598, GO:0048729, GO:0048546, GO:0048704, GO:0060993, GO:0072028,
GO:0035136, GO:0060571, GO:0032990, GO:0000904, GO:0048858, GO:0010927, GO:0048812, GO:0032989, GO:0000902,
GO:0000904, c5:1089, GO:0048813, GO:0048814, GO:0010769, GO:0022604, GO:0048667,
Intemediate ﬁlament GO:0045104, c5:81, c5:290, c5:909, GO:0045103, GO:0032231, GO:0005882, GO:0045111, GO:0045109, GO:0045095, c5:891
Hair follicle GO:0001942, GO:0031069, GO:0042633, GO:0022405
Proliferation GO:0008284, GO:0032944, GO:0050670, GO:0070663, GO:0042129, GO:0032943, GO:0046651, GO:0070661, GO:0042127,
GO:0032946, GO:0050671
Wnt pathway GO:0007223, mmu04310, GO:0030178
Immunity GO:0006955, GO:0002263, GO:0002366, c5:662, GO:0002697, c5:736, c2:117, c5:1113, c2:332, c2:262, c5:1615, mmu05320,
GO:0002822, c5:495, c5:1199, GO:0002455, mmu04672, c5:854, GO:0002252, GO:0016064, GO:0002684, GO:0002699,
GO:0002460, GO:0002250, GO:0006959, GO:0050776, GO:0002824, GO:0002821, GO:0002819, GO:0002682
Proteinaceous extracellular matrix GO:0005578, GO:0031012, GO:0044421, GO:0005615, c5:254
MAP3K1-repressed genes in IE
Striated muscle cell differentiation GO:0051146, GO:0055002, mmu04260, GO:0060537, GO:0005865, c5:1063, c2:1227, GO:0003009, c5:46, c5:1040,
GO:0051149, GO:0046716, c2:1154, c5:249, c2:212, GO:0006941, c2:1160
Cytoskeleton organization GO:0007010, GO:0030036, GO:0030029, GO:0003779, GO:0015629, c5:891, GO:0015630, c5:174, GO:0070507, c5:84,
c5:354, GO:0051493, c2:1960, GO:0000226, mmu04810, c5:314, c2:242
C. Jin et al. / Developmental Biology 374 (2013) 96–107100with similar frequencies in the eyelid dermis of all fetuses examined,
they were clearly more abundant in the LE epithelium of wild type
than Map3k1DKD/DKD fetuses.
H3 phosphorylation alone, however, is insufﬁcient to support a
role of MAP3K1 in proliferation, because besides being a marker for
mitosis, H3 phosphorylation is also a common nucleosomal response
to diverse stimuli associated with inducible transcriptional gene
activation. To further evaluate the role of MAP3K1 in proliferation,
we examined the array data for the expression of cell cycle markers
(Supplemental Table XXVIII). Of the 127 cell cycle regulators, only
2 were found differentially expressed between wild type and
Map3k1DKD/DKD LE cells, One is Mcm2, encoding minichromosome
maintenance complex component 2 regulating S phase DNA replica-
tion initiation and elongation, and the other is Abl1, encoding a non-
receptor tyrosine-protein kinase that coordinates actin remodeling
and thereby cell growth and survival. The expression of Mcm2 and
Abl1was reduced by 45% and 36%, respectively, in theMap3k1DKD/DKD
cells. On the other hand, Mki67, encoding an antigen identiﬁed by
monoclonal antibody Ki-67, was expressed at similar level in wild
type and Map3k1DKD/DKD LE cells. Ki-67 is known to be associated
with and necessary for cellular proliferation. These results therefore
suggest that although MAP3K1 enhances mitogen expression and H3
phosphorylation, it does not promote LE cell proliferation.
Crosstalk between MAP3K1 and morphogenetic signaling pathways
Mutations in Wnt, Sonic hedgehog (SHH), BMP/Activin B, FGF and
EGF/TGFa amongst others cause mice to develop an EOB phenotype,
suggesting that embryonic eyelid closure is regulated by multiplesignaling pathways (Gage et al., 2008; Huang et al., 2009; Luetteke
et al., 1993; Mine et al., 2005). Although how these signals interact to
coordinate eyelid development is still an open question, we have
shown, using genetic and molecular approaches, that MAP3K1
connects several of the pathways into a signaling network (Geh
et al., 2011). In this network, EGF/TGFa activates MAP3K1 expression,
while MAP3K1 in turn transduces Activin B signals to activate the
JNK-c-Jun cascades. The present gene expression data suggest that
Wnt and SHH are additional components of the network (Table 3).
Wnt functions through activation of Frizzled receptors, leading to
phosphorylation of Dishevelled (Dsh) proteins. Phosphorylated Dsh
recruits the b-catenin destruction complex of axin/APC/GSK3b to the
membrane, resulting in stabilization of b-catenin (Cadigan and Liu,
2006). Although MAP3K1 ablation did not affect the expression of
different Wnt proteins or of their receptors and the members of the
b-catenin destruction complex, it decreased the expression of six
genes in LE and one gene in IE cells implicated in Wnt signaling
(Table 3 and Supplemental Tables XV, XXII and XXIX). qRT-PCR
conﬁrmed that in the LE cells, MAP3K1 ablation reduced the expres-
sion of secreted frizzled-related protein 4 (Sfrp4), a soluble modulator
of Wnt signaling, and in the IE cells, MAP3K1 ablation reduced the
expression of the Wnt antagonist DKK2 (Fig. 4A).
Activation of Wnt leads to stabilization and subsequent transloca-
tion of b-catenin into the nucleus. Once inside the nucleus, b-catenin
forms complexes with the DNA-binding transcription factor LEF/TCF
to regulate Wnt-target genes (Cadigan and Liu, 2006). To evaluate
whether MAP3K1 ablation affected the activity of Wnt, we examined
wild type and Map3k1DKD/DKD for cellular localization of b-catenin.
We found that in the eyelid epithelium of wild type fetuses, b-catenin
Table 2
MAP3K1-dependent genes in morphogenesis of LE eyelid epithelium.
Symbol Name Fold wt
vs. ko
p value
Morphogenesis
Sfrp4 Secreted frizzled-related protein 4 2.95 0.0246
Tdgf1 Teratocarcinoma-derived growth
factor 1
2.21 0.00231
Krt17 Keratin 17 2.18 0.00178
Krt27 Keratin 27 2.13 0.0364
Dmp1 Dentin matrix protein 1 2.06 0.0367
Arhgdia Rho GDP dissociation inhibitor (GDI)
alpha
2 0.0371
Mapk14 Mitogen-activated protein kinase 14 1.79 0.0224
Fgf7 Fibroblast growth factor 7 1.7 0.00466
Gli2 GLI-Kruppel family member GLI2 1.68 0.00222
Efna1 Ephrin A1 1.67 0.0443
Spry2 Sprouty homolog 2 (Drosophila) 1.64 0.00334
Trps1 Trichorhinophalangeal syndrome I
(human)
1.61 0.00281
Inpp5k Inositol polyphosphate 5-phosphatase K 1.58 0.0157
Gnaq Guanine nucleotide binding protein,
aq Polypeptide
1.57 0.0129
Cbfa2t2 Core-binding factor, runt domain, a2 1.52 0.0161
Aqp1 Aquaporin 1 1.5 0.00721
Fgf9 Fibroblast growth factor 9 1.5 0.0277
Hoxd8 Homeo box D8 1.57 0.006
Gamt Guanidinoacetate methyltransferase 1.62 0.00609
Lor Loricrin 1.62 0.0063
Ift52 Intraﬂagellar transport 52 homolog
(Chlamydomonas)
1.65 0.0269
Ednrb Endothelin receptor type B 1.72 0.0343
Tgfbr1 Transforming growth factor, beta
receptor I
1.75 0.0442
Chl1 Cell adhesion molecule homology to
L1CAM
1.76 0.00862
Nr3c1 Nuclear receptor subfamily 3, group C,
member 1
1.85 0.00392
Hes1 Hairy and enhancer of split 1
(Drosophila)
1.86 0.0119
Ermn Ermin, ERM-like protein 2.07 0.0214
Serpina1b Serine preptidase inhibitor, clade A,
member 1B
2.12 0.0246
Crygs Crystallin, gamma S 2.16 0.012
Aldh1a1 Aldehyde dehydrogenase family 1,
subfamily A1
2.65 0.000419
Cryaa Crystallin, alpha A 2.92 0.0184
Ntf3 Neurotrophin 3 2.96 0.0184
Vpreb1 Pre-B lymphocyte gene 1 7.5 0.00505
Actin cytoskeleton
Krt17 Keratin 17 2.18 0.00178
Acta2 Actin, alpha 2, smooth muscle, aorta 2.06 0.00798
Palld Palladin, cytoskeletal associated
protein
1.77 0.0171
Gmfb Glia maturation factor, beta 1.73 0.00259
Fgf7 Fibroblast growth factor 7 1.7 0.00466
Aqp1 Aquaporin 1 1.5 0.00721
Fgd4 FYVE, RhoGEF and PH domain
containing 4
1.53 0.0253
Cryab Crystallin, alpha B 1.71 0.00509
6330503K22Rik RIKEN cDNA 6330503K22 gene 2 0.00393
Ermn Ermin, ERM-like protein 2.07 0.0214
Tnnt3 Troponin T3, skeletal, fast 2.25 0.0169
Cryaa Crystallin, alpha A 2.92 0.0184
Tac1 Tachykinin 1 -3 0.00299
S100a9 S100 calcium binding protein A9
(calgranulin B)
3.71 0.0274
Table 3
The morphogenetic pathways affected by MAP3K1.
Symbol Name Fold p value
wt vs. ko
LE
Wnt pathway
Sfrp4 Secreted frizzled-related protein 4 2.95 0.0246
1500003O03Rik RIKEN cDNA 1500003O03 gene 1.87 0.0322
Nkd1 Naked cuticle 1 homolog (Drosophila) 1.58 0.0161
Ddb1 Damage speciﬁc DNA binding protein
1
1.5 0.0436
Fgf9 Fibroblast growth factor 9 1.5 0.0277
Rnf138 Ring ﬁnger protein 138 1.53 0.0205
Rbx1 Ring-box 1 1.64 0.0144
Shh pathway
Gli2 GLI-Kruppel family member GLI2 1.68 0.00222
Fgf9 Fibroblast growth factor 9 1.5 0.0277
Ift52 Intraﬂagellar transport 52 homolog 1.65 0.0269
IE
Wnt pathway
Dkk2 Dickkopf homolog 2 (Xenopus laevis) 1.69 0.0075
Table 4
SRF and AP-2 expression in LE cells.
Symbol Name Fold wt vs. ko p value
SRF in LE
Srf Serum response factor 1.0379 0.782277
Srfbp1 Serum response factor binding
protein 1
1.39217 0.070441
SRF partners in LE
Tfpt TCF3 (E2A) fusion partner 1.509145 0.096659
Tcf12 Transcription factor 12 1.362548 0.038529
Tcf15 Transcription factor 15 1.031842 0.77846
Tcf19 Transcription factor 19 1.127725 0.42201
Tcf20 Transcription factor 20 1.129748 0.3011
Tcf21 Transcription factor 21 1.29607 0.440777
Tcf23 Transcription factor 23 1.05431 0.635334
Tcf25 Transcription factor 25 1.169354 0.157347
Tcf3 Transcription factor 3 1.25816 0.118781
Tcf4 Transcription factor 4 1.194572 0.28643
Tcf7 Transcription factor 7, T-cell speciﬁc -1.02798 0.801476
Tcf7l2 Transcription factor 7-like 2, 1.734291 0.073474
AP-2 in LE
Tcfap2a Transcription factor AP-2, alpha 1.178243 0.362185
Tcfap2b Transcription factor AP-2 beta 1.351236 0.05086
Tcfap2c Transcription factor AP-2, gamma 1.06344 0.628626
Tcfap2d Transcription factor AP-2, delta 1.05525 0.700427
Tcfap2e Transcription factor AP-2, epsilon 1.00627 0.965194
AP-2 in IE
Tcfap2a Transcription factor AP-2, alpha 1.692202 0.003414
Tcfap2b Transcription factor AP-2 beta 1.484459 0.009824
Tcfap2c Transcription factor AP-2, gamma 1.12393 0.216539
Tcfap2d Transcription factor AP-2, delta 1.8996 0.402644
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in that of knockout fetuses it displayed a dispersed distribution in
both cytosol and nucleus (Fig. 4B). To evaluate whether MAP3K1
ablation increased b-catenin activity, we introduced a luciferase
reporter driven by the TCF/LEF DNA-binding sites into wild type
and Map3k1DKD/DKD ﬁbroblasts and measured luciferase expression(Brantjes et al., 2002). The results showed that Wnt3a expression
induced luciferase activity by 3-fold in wild type cells and more
than 10-fold in knockout cells (Fig. 4C). Similarly, while expression
of wild type MAP3K1 had minimal effects, expression of kinase-
inactive MAP3K1 {MAP3K1(KM)} signiﬁcantly elevated TCF/LEF-luc
activity in HEK293 cells either untreated or treated with LiCl, which
activates Wnt through the inhibition of GSK3 activity (Stambolic
et al., 1996) (Fig. 4D).
Sonic hedgehog (SHH) is an important signal for EMT and crucial
for embryonic eyelid closure (Huang et al., 2009; Lipinski et al., 2008;
Young et al., 2000). This pathway is initiated by binding of SHH to its
receptor PTCH1 that activates Smoothened. Smoothened in turn
Table 5
Differentiation programs affected by MAP3K1.
Symbol Name Fold
wt vs.
ko
p value
LE epithelium
Hair follicle
Krt17 Keratin 17 2.18 0.00178
Krt27 Keratin 27 2.13 0.0364
Fgf7 Fibroblast growth factor 7 1.7 0.00466
Lens crystallin
Cryaa Crystallin, alpha A 2.92 0.0184
Cryab Crystallin, alpha B 1.71 0.00509
Cryba1 Crystallin, beta A1 3.35 0.00645
Cryba2 Crystallin, beta A2 4.71 0.0188
Crybb1 Crystallin, beta B1 1.95 0.0392
Cryge Crystallin, gamma E 2.83 0.00108
Crygf Crystallin, gamma F 1.81 0.00983
Crygn Crystallin, gamma N 3.69 0.0336
Crygs Crystallin, gamma S 2.16 0.012
Lim2 Lens intrinsic membrane protein 2 1.62 0.00414
IE epithelium
Hair follicle
Krt71 Keratin 71 2.17 0.0106
Krt25 Keratin 25 1.96 0.00253
Krt27 Keratin 27 1.9 0.00839
Tchh Trichohyalin 2.16 0.00466
Krtap7-1 Keratin associated protein 7-1 1.93 0.0258
Krt73 Keratin 73 1.67 0.0156
Muscle
differentiation
Murc Muscle-related coiled-coil protein 1.52 0.0102
Rb1 Retinoblastoma 1 1.57 0.00341
Mef2c Myocyte enhancer factor 2C 1.61 0.00766
Zfp238 Zinc ﬁnger protein 238 1.71 0.00389
Atp1b4 ATPase, (Naþ)/Kþ transporting, b 4 1.84 0.0168
Acta1 Actin, alpha 1, skeletal muscle 2.27 0.0474
Mylpf Myosin light chain fast skeletal
muscle
2.51 0.0458
Mybpc1 Myosin binding protein C 2.63 0.0392
Tnni2 Troponin I, skeletal, fast 2 2.74 0.0316
Tnnt3 Troponin T3, skeletal, fast 3.76 0.0162
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Fig. 3. MAP3K1 regulates morphogenesis and H3 phosphorylation. (A) Wild type
andMap3k1DKD/DKD fetuses at E15.5 were used for LCM and RNA isolation. Samples
of LE eyelid epithelium were analyzed by qRT-PCR for speciﬁc genes as indicated.
Results are shown as mean7SD from at least 3 samples of each genotype and
triplicate PCR of each sample. Relative expression was calculated as in Fig. 1.
(B) The E15.5 wild type and Map3k1 DKD/DKD fetuses were subjected to immunos-
taining using anti-phospho histone 3 (p-H3, Red) and nuclei were stained with
Hoechst (Blue). Pictures were taken under Axio ﬂuorescence microscopy. Dotted
lines mark the eyelid epithelium (Ep) laying over the dermis (De). The percentage
of pH3-positive cells in the tip of eyelid epithelium was calculated and the results
are expressed as the mean7SD from 6 wild type and 10 knockout eyes examined.
Statistic analyses were done by Student t-test, nnnpo0.001 is considered
signiﬁcant.
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target gene expression (Riobo and Manning, 2007). We found that
several members of this pathway, including Gli2 and its target gene
Fgf9, were down-regulated in Map3k1DKD/DKD LE epithelium
(Pantalacci et al., 2008) (Table 3). Using qRT-PCR, we conﬁrmed
that Gli2 mRNA was less abundant in the LE epithelium of
Map3k1DKD/DKD than in that of wild type (Fig. 4A), suggesting that
MAP3K1 enhances SHH signaling. In summary, our results suggest
that the MAP3K1-mediated signaling network has an expansive
capacity, as it not only involves TGFa and Activin B signals, but also
connects to Wnt and SHH signals.
MAP3K1 activates AP-2a, SRF and their pathways
To identify potential transcription factors acting downstream of
MAP3K1, we determined whether the frequency of known transcrip-
tion factor binding motifs was greater in the regulatory elements of
genes differentially expressed in LE cells. MAP3K1 is a 196 kDa
protein containing a N-terminal ubiquitin ligase domain and a
C-terminal kinase domain (Lu et al., 2002; Xia et al., 2000). The
MAP3K1-b-gal fusion protein derived from the Map3k1DKD allele,
while retaining the N-terminal domain, lacks the C-terminal domain.
Given that Map3k1DKD/DKD and Map3k1 / mice both exhibit EOB, it
is likely that the kinase, but not the ubiquitin ligase activity is
required for embryonic eyelid closure (Yujiri et al., 2000; Zhanget al., 2003). Previously, we have shown that the kinase activity of
MAP3K1 is responsible for activation of the JNK-c-Jun cascades and
the AP-1 transcription complex (Geh et al., 2011; Takatori et al.,
2008). Our TF binding motifs analyses, however, did not ﬁnd AP-1
target sequences over-represented among genes up-regulated by
MAP3K1, suggesting that AP-1 was not directly responsible for
MAP3K1-dependent gene expression. On the other hand, we
identiﬁed AP-2 and SRF as two factors whose binding sites were
highly enriched among genes up-regulated by MAP3K1 (Supple-
mental Table XXX).
The signiﬁcant enrichment of AP-2 target genes, combined with
the evidence that AP-2a knockout mice exhibit the EOB phenotype,
led us to explore whether AP-2 was directly affected by MAP3K1
(West-Mays et al., 1999). The AP-2 family has ﬁve members: AP-2a,
AP-2b, AP-2g, AP-2d, and AP-2e, all possessing a basic helix–loop–
helix (bHLH) domain at the C-terminus and a glutamine- and proline-
rich domain at the N-terminus (Eckert et al., 2005). These AP-2
proteins form homodimers and heterodimers that bind to the
palindromic sequence GCCN3GGC within multiple gene promoters
(Hilger-Eversheim et al., 2000). In our array data, although the
expression of other AP-2 members was unaffected by MAP3K1
ablation, the expression of AP-2a and AP-2b was reduced in
Map3k1DKD/DKD cells (Table 4). Real time RT-PCR conﬁrmed the
reduction of Ap2a expression by MAP3K1 ablation in LE and IE cells
(Fig. 5A). A well recognized function of AP-2a is the modulation of
epidermal lineage speciﬁcation and hair follicle gene expression
(Panteleyev et al., 2001; Wang et al., 2008). Accordingly, the IE and
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Fig. 4. MAP3K1 regulates morphogenetic signaling pathways in LE eyelid epithelium. (A) Total RNA isolated from LE or IE epithelium of E15.5 wild type andMap3k1DKD/DKD
fetuses were examined by qRT-PCR for mRNA of Gli2 and Sfrp4 in LE and Dkk2 in IE cells. Relative expression was calculated as described in Fig. 1. The results shown are the
mean7SD from at least 3 samples of each genotype and triplicate PCR of each sample. Statistical analyses were done by Student t-test, nnnpo0.001 was considered
signiﬁcant. (B) Wild type and Map3k1DKD/DKD fetuses at E15.5 were subjected to immunostaining using anti-b-catenin (Red) and nuclei were stained with Hoechst (Blue).
Pictures were taken under low and high (insets) magniﬁcation. Dotted lines mark the boundary between epithelium and dermis. LE: leading edge eyelid; IE: Inner eyelid;
De: Dermis; Co: cornea. Scale bar represents 50 mm. (C) Wild type andMap3k1DKD/DKD ﬁbroblasts were co-transfected with TCF/LEF-luc and CMV-renilla luciferase reporter
plasmids in the presence or absence of plasmids for Wnt3a for 24 h, or (D) HEK293 cells were transfected with TCF/LEF-luc and CMV-renilla luciferase reporter plasmids in
the presence or absence of expression vectors for MAP3K1(WT) or MAP3K1(KM) and of LiCl treatment for 24 h. The relative luciferase activity was calculated based on the
ratio of ﬁreﬂy to renilla activities, with the values in control wild type cells or empty vector transfected untreated cells set as 1. Statistic analyses were done by Student
t-test, nnnpo0.001 are considered signiﬁcant.
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Fig. 5. Transcription factors affected by MAP3K1. (A) Total RNA isolated from LE
and IE epithelium of wild type and Map3k1DKD/DKD fetuses at E15.5 was used for
qRT-PCR determination of Ap2a mRNA expression. relative to Gapdh and com-
pared to the expression in wild type cells, set as 1. The results are shown as
mean7SD from at least 3 samples of each genotype and triplicate PCR of each
sample. Statistical analyses were done by Student t-test, nnpo0.01 and
nnnpo0.001 are considered signiﬁcant. (B) HEK293 cells were transfected with
luciferase reporter plasmids for the different transcription factors, together with a
CMV-renilla luciferase reporter, with or without expression of active MAP3K1. The
relative luciferase activity was calculated based on the ratio of ﬁreﬂy to renilla
activities, with the values in control wild type cells set as 1. Statistical analyses
were done by Student t-test, nnpo0.01 and nnnpo0.001 are considered signiﬁcant.
LE: leading edge eyelid; IE: Inner eyelid.
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expression than those of the wild type fetuses (Table 5), suggesting
that the MAP3K1-AP-2 axis may be involved in hair follicle gene
expression.The SRF is a transcription factor that binds to CC(AT)6GG DNA
sequences, as part of the serum response elements (SREs) located in
the promoters of target gene (Shaw et al., 1989). Because our
expression data showed that MAP3K1 ablation did not alter SRF
expression (Table 4), we tested whether MAP3K1 could affect SRF
activity (Soh et al., 1999). We transfected HEK293 cells with luciferase
reporter vectors responsive to transcription factors, including AP-1,
SMAD and SRF; in some experiments, we co-transfected plasmids for
active MAP3K1. We found that active MAP3K1 did not affect SMAD-
dependent luciferase activity (SBE-luc), but it signiﬁcantly stimulated
SRF- as well as AP-1-dependent activity (Fig. 5B). SRF binding motifs
are frequent in the promoter of genes controlling cell motility, such as
Fgf7, a2-actin, Transgelin and keratin 17, underscoring the involvement
of the MAP3K1-SRF axis in LE cell migration (Table 6).
Differentiation programs in LE and IE epithelium are
affected by MAP3K1
An unexpected ﬁnding from the gene expression data was that
MAP3K1 affected the transcription of multiple lineage differentia-
tion genes (Table 5). Speciﬁcally, it inhibited crystallin expression
in LE epithelium, and skeletal muscle genes in IE epithelium, and
induced hair follicle genes in both LE and IE epithelium.
Although crystallins are known as structural proteins of the lens
and cornea responsible for the transparency of the eye, crystallin gene
transcripts were detected in the LE epithelial cells. At least 10
crystallin mRNAs were signiﬁcantly more abundant in knockout than
wild type LE cells. RT-PCR conﬁrmed that three of these, Crystallinba1,
Crystallinba2 and Crystallingn, were expressed at 15–20-fold higher
C. Jin et al. / Developmental Biology 374 (2013) 96–107104levels in the knockout cells (Fig. 6A). PAX6 is a master transcription
regulator of crystalline genes (Graw, 2009; Grindley et al., 1995;
shery-Padan et al., 2000). However, MAP3K1 ablation did not alter
either the expression of members of the Pax6 family, or the expres-
sion of PAX6 co-factors, including the large Maf proteins, Mafa and
Mafb, Pax2, Prox1, Six3, Pitx3, FoxE3, Sox1 and Sox2, and Otx2 (Cvekl
and Duncan, 2007) (Supplemental Tables XXXII and XXXIII). On the
other hand, we found that MAP3K1 ablation caused down-regulation
of FGF and up-regulation of Wnt signaling, whereas FGF and Wnt
may in turn regulate crystallin gene transcription (Chen et al., 2006)
(Supplemental Tables XXIX and XXXIV).Table 6
MAP3K1-dependent genes enriched for SRF binding sites.
Symbol Name Fold wt vs. ko p value
Krt17 Keratin 17 2.18 0.00178
Acta2 Actin, alpha 2, smooth muscle, aorta 2.06 0.00798
Pcdhb15 Protocadherin beta 15 1.98 0.0221
Olfr1290 Olfactory receptor 1290 1.89 0.0172
Tagln Transgelin 1.84 0.0159
Ndufa7 NADH dehydrogenase (ubiquinone) 1a7 1.83 0.035
Mapk14 Mitogen-activated protein kinase 14 1.79 0.0224
Dcaf8 DDB1 and CUL4 associated factor 8 1.73 0.0162
Fgf7 Fibroblast growth factor 7 1.7 0.00466
U2af1l4 U2 small nuclear RNA auxiliary Factor 1–4 1.67 0.0467
Sertad4 SERTA domain containing 4 1.64 0.0088
Fig. 6. MAP3K1 affects differentiation of LE and IE eyelid epithelium. Total RNA isola
Map3k1DKD/DKD E15.5 fetuses were used for qRT-PCR using gene primers for (A) the len
Relative expression was calculated as in Fig. 1. The results shown are the mean7SD fro
analyses were done by Student t-test, nnnpo0.001 are considered signiﬁcant. (C) Th
were examined by immunohistochemistry using anti-a2 actin (green) for smooth mus
labeled with Hoechst (blue). Scale bar¼100 mm. LE: leading edge eyelid; IE: Inner
sections of control and Map3k1DKD/DKD mice at P1. Epidermis, dermis, representati
(H&E, Scale bar¼50 mm).A number of skeletal muscle gene transcripts were expressed at
higher levels in Map3k1DKD/DKD than in wild type IE epithelial cells
(Table 5). qRT-PCR showed that ﬁve genes in this category, including
actin a1 (Acta1), fast skeletal phosphorylatable myosin light chain
(Mlcpf), myosin binding protein C (Myfopc1), troponin I type 2 (Tnni2)
and troponin T3 (Tnnt3), were expressed more abundantly in the
knockout cells (Fig. 6B). Although these observations implied that
MAP3K1 repressed skeletal muscle differentiation in the IE epithe-
lium, immunohistochemical studies detected no trace of skeletal
muscle (SK myosin) or smooth muscle (a-SM actin) proteins in the
IE of fetuses at various embryonic stages of either genotypes (Fig. 6C).
Immunohistochemistry detected instead inferior tarsal muscles
(a-SM actin positive) in the lower eyelids adjacent to the IE
epithelium and the bundle of skeletal muscles (a-SM actin and SK
myosin positive) located in the middle of the developing eyelids. Both
muscles displayed aberrant differentiation patterns in theMap3k1DKD/
DKD fetuses. Based on these observations, we speculate that the IE
epithelial cells captured by LCM might be contaminated with nearby
myocytes. This is unlikely to be the case, however, because our gene
expression analysis of cultured keratinocytes from wild type and
Map3k1DKD/DKDmice showed that loss of MAP3K1 led to the increased
expression of a number of muscle-speciﬁc genes (Deng et al., 2006)
(Table 7). Some of the genes, such as Mlcpf and Acta1, were affected
by MAP3K1 ablation similarly in keratinocytes and IE epithelium.
Repression of muscle-speciﬁc gene transcription therefore seems to
be an intrinsic property of MAP3K1 in epithelial cells.ted from (A) LE; (B) IE epithelium; and (D) both LE and IE cells of wild type and
s crystallin genes indicated, (B) skeletal muscle genes, and (D) hair follicle genes.
m at least 3 samples of each genotype and triplicate PCR of each sample. Statistical
e developing eyes of wild type and Map3k1DKD/DKD fetuses at E16.5 and E18.5
cle (asterisks) and anti-SK myosin (red) for skeletal muscle (arrows). Nuclei were
eyelid epithelium was marked with dotted lines. (E) Longitudinal haired skin
ve telogen hair follicles and adnexa display no overt structural abnormalities
Table 7
MAP3K1 regulates differentiation programs in vitro.
Symbol Name Fold
wt vs. ko
p value
Mylpf Myosin light chain, fast skeletal muscle 4.82766 0.0002
Myh3 Myosin, heavy polypeptide 3, skeletal muscle 3.05089 0.0013
Acta1 Actin, alpha 1, skeletal muscle 2.68425 0.0161
Spna1 Spectrin alpha 1 2.27656 0.0002
Gys1 Glycogen synthase 1, muscle 2.21138 0.0003
Tnnt1 Troponin T1, skeletal, slow 1.51199 0.0009
Pygm Muscle glycogen phosphorylase 1.51135 0.0003
Eno3 Enolase 3, beta muscle 1.48959 0.0028
Tnnc2 Troponin C2, fast 1.43915 0.0235
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expression of genes implicated in hair follicle development, with
lower levels in Map3k1DKD/DKD than in wild type (Table 5 and
Fig. 6D). MAP3K1 ablation decreased the expression of keratin 17,
a hair follicle and epidermal appendage marker; it also down-
regulated the expression of keratins 25 and 27, which are type I
intermediate ﬁlaments, and keratins 71 and 73, which are type II
intermediate ﬁlaments, and trichohyalin (Tchh) and hair keratin-
associated proteins (KRTAP), which are intermediate ﬁlament-
associated proteins speciﬁcally implicated in inner root sheath of
hair follicles(Gritli-Linde et al., 2007; Strnad et al., 2011). These
observations led us to ask whether MAP3K1 ablation affected the
development and structure of hair follicle and epidermis. Micro-
scopic examination of representative dorsal haired skin long-
itudinal sections of postnatal day 1 (P1) revealed no overt
structural changes in Map3k1DKD/DKD hair follicles, epidermis, or
dermis when compared to controls (Fig. 6E). Additionally, no
grossly appreciable skin or coat abnormalities are present in
knockout mice. Whether the altered gene expression led to
discrete ultrastructural changes in hair follicle components was
not determined.Discussion
Cell heterogeneity and the temporal-spatial nature of gene regula-
tion constitute a major challenge to study gene expression in
developing tissues. Our initial attempt to microarray studies used
whole eyelid tissues macro dissected from wild type andMap3k1DKD/
DKD fetuses, which generated dispersed expression patterns with no
outstanding signatures. We then modiﬁed the strategy by using LCM
to capture a highly enriched cell population. The LCM samples exhibit
abundant expression of epithelial-speciﬁc genes, but they also have a
few detectable mesenchymal markers, such as Vimentin and Fgf7.
Because these markers are detected also in the in vitro cultured
keratinocytes that do not contain mesenchymal cells (Supplemental
Table XXXV), their presence in the LCM samples may not be a sign of
mesenchymal cell contamination. Nevertheless, the LCM samples
have signiﬁcantly improved array quality, resulting in reliable gene
expression signatures with considerably reduced noise and variabil-
ity. By integrating LCM with expression arrays, we identiﬁed gene
transcription signatures in subgroups of eyelid cells in whichMAP3K1
is most abundantly expressed. Strikingly, the transcriptome data
reveal an extremely small overlap in MAP3K1 affected genes between
LE and IE, suggesting that even though MAP3K1 is similarly
expressed, it has distinct spatial-temporal activities. In the LE, the
subset cells most relevant to embryonic eyelid closure, MAP3K1 is
shown to regulate actin cytoskeleton, EMT and morphogenesis. Since
these signatures are identiﬁed at E15.5, a developmental stage priorto eyelid closure, they likely characterize molecular and cellular
events through which MAP3K1 controls embryonic eyelid closure.
Results from the current work have extended our view of the
signaling properties of MAP3K1, because they suggest that
MAP3K1 is not only the downstream transducer of the TGFa/
EGF and TGFb/activin B signals, but can also act as an upstream
modulator of Wnt and SHH signals. How MAP3K1 establishes a
crosstalk with these pathways is not understood at the molecular
level, with many possible direct and indirect mechanisms. On the
one hand, MAP3K1 may activate the JNK cascades to affect
directly the expression and activity of Wnt and SHH; on the other
hand, it may act through an intermediary, such as FGF, or a
biological process, such as cell migration, to inﬂuence indirectly
Wnt and SHH (Grotewold and Ruther, 2002; Huang et al., 2009;
Weston et al., 2003). Our results suggest that MAP3K1 may have
more expansive signaling properties than previously thought, as it
appears to interact with many developmental pathways to
coordinate the morphogenetic programs in the LE cells.
The gene expression data suggest that MAP3K1 attenuates Wnt
signaling, a conclusion consistent with the notion that Wnt inhibition
is necessary for embryonic eyelid closure and with the observation
that knocking out the Wnt antagonist DKK2 results in EOB (Gage
et al., 2008). In the LE cells of theMap3k1DKD/DKD fetuses, however, we
note that b-catenin is not highly accumulated in the nucleus but
rather is dispersed throughout the cells. These observations raise a
possibility that MAP3K1 ablation causes just a slight disturbance of
the Wnt signaling. While this possibility is yet to be tested, a recent
study showed an opposite effect of MAP3K1 on Wnt signaling. It was
observed that in colorectal cancer cells MAP3K1 interacted with the
Wnt negative regulator Axin1 and caused the activation of b-catenin
and Wnt target genes (Sue et al., 2010). This function depended on
MAP3K1’s E3 ubiquitin ligase activity mediated through its RING
domain, and was independent of its kinase activity, required for
embryonic eyelid closure. It is hence possible that through differential
usage of its functional domains, MAP3K1 can either activate or repress
Wnt signaling in a cell type- and biological process-dependent
manner.
We have previously shown that MAP3K1 is required for
optimal c-Jun N-terminal phosphorylation as well as AP-1 activity
in LE cells (Geh et al., 2011; Takatori et al., 2008). In agreement
with these ﬁndings, we ﬁnd that MAP3K1 stimulates AP-1 activity
in HEK293 cells. It has long been held that MAP3K1 regulates
eyelid closure through activation of c-Jun and AP-1 and their
downstream genes; however, the genetic evidence challenges this
idea. Genetic studies have shown that although c-Jun expression
is essential for embryonic eyelid closure, its N-terminal phos-
phorylation is dispensable for this function (Behrens et al., 1999;
Li et al., 2003; Zenz and Wagner, 2006). Our TF binding site
enrichment analyses support the genetic evidence. The enrich-
ment analysis results show that AP-1 binding sites are not found
among the genes up-regulated in wild type LE cells, suggesting
that c-Jun/AP-1 activation by MAP3K1 either makes trivial con-
tributions to eyelid closure or contributes indirectly by facilitating
the functions of other transcription factors. On the other hand,
binding sites for AP-2 and SRF are highly enriched among genes
up-regulated by MAP3K1; correspondingly, MAP3K1 is required
for optimal AP-2 expression and SRF activity. These observations
are consistent with the fact that both AP-2a and SRF are
implicated in eyelid development, as shown by the EOB pheno-
type of their knockout mice (Verdoni et al., 2010; West-Mays
et al., 1999). The AP-2 and SRF are known to play crucial roles in
differentiation, therefore, their dysregulation may be responsible
for aberrant differentiation of epithelium, hair follicles, muscle
and lens placode in the Map3k1DKD/DKD cells (Aline and
Sotiropoulos, 2012; Wang et al., 2008; Wenke and Bosserhoff,
2010; West-Mays et al., 1999). Taken together, our results suggest
C. Jin et al. / Developmental Biology 374 (2013) 96–107106that eyelid morphogenesis is regulated by a novel mechanism in
which MAP3K1 acts through AP2 and SRF to control gene expression.
The gene expression data also reveal the unique signatures of
MAP3K1 in lineage-speciﬁc gene transcription in the LE and IE
epithelium. Speciﬁcally, there is a clear inverse relationship
between MAP3K1 and transcription of crystallin genes in LE cells
and skeletal muscle genes in IE cells. In addition, there is a parallel
relationship between MAP3K1 and transcription of hair follicle
genes in both LE and IE epithelium. An important caveat is that
gene transcription signatures may not accurately reﬂect func-
tional endpoints, because there is scant evidence to indicate that
MAP3K1 ablation alters any of the differentiation programs at the
protein level. One possible explanation is that the developing cells
have powerful post-transcriptional mechanisms, such as non-
coding RNAs, to control differentiation. These machineries will
allow efﬁcient translation of speciﬁc mRNA in permissive cells,
but impair translation in non-permissive cells.
Collectively, this work provides an example illustrating the use of
LCM, gene knockout system and expression array to gain mechanistic
understanding of gene functions in developmental tissues. With this
approach, we have identiﬁed novel molecular and signaling pathways
through which MAP3K1 regulates embryonic eyelid closure.Acknowledgements
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